Showing results (81-90 of 1,382) with videos related to

Sort By:
Pageof 139
ACS Pharmacology & Translational Science|April 8, 2020
The Brain-Heart Axis: Alzheimer's, Diabetes, and HypertensionAndrew S Riching, Jennifer L Major, Pilar Londono, et al.
ACS Pharmacology & Translational Science|April 8, 2020
IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical StudiesChantal Donovan, Philip M Hansbro
ACS Pharmacology & Translational Science|April 8, 2020
The Discovery of Suvorexant: Lessons Learned That Can Be Applied to Other CNS Drug Development EffortsJason M Uslaner, William J Herring, Paul J Coleman
ACS Pharmacology & Translational Science|May 20, 2022
Automated Computer Software Assessment of 5-Hydroxytryptamine 2A Receptor-Mediated Head Twitch Responses from Video Recordings of MiceGrant C Glatfelter, Michael R Chojnacki, Shelby A McGriff, et al.
ACS Pharmacology & Translational Science|May 20, 2022
Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein SubunitsJan Hendrik Voss, Andhika B Mahardhika, Asuka Inoue, et al.
ACS Pharmacology & Translational Science|June 17, 2021
A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein DynamicsJonas Gossen, Simone Albani, Anton Hanke, et al.
ACS Pharmacology & Translational Science|June 17, 2021
Correction to "Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir"Ting Chen, Cheng-Yin Fei, Yi-Ping Chen, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Prospective Evaluation of the Transparent, Elastomeric, Adaptable, Long-Lasting (TEAL) RespiratorAdam J Wentworth, James D Byrne, Sirma Orguc, et al.
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
ACS Pharmacology & Translational Science|November 15, 2021
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2Ke Liu, Rongfeng Zou, Wenqiang Cui, et al.
Pageof 139